There’s a new drug on the market that’s up to 99 percent effective at
curing hepatitis C, an often deadly liver virus. The drug is known as
Some Georgians will get it.
But thousands of HIV-positive Georgians, who also have hepatitis C, won't.
The reason? Cost.
Read more and listen to the podcast here....
Labels: access restrictions, Georgia, medicaid, NPR, V-pak